Stocksigma LogoStocksigma Logo

Aarti Pharmalabs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 61,045 (+45.9% YoY | +13.9% QoQ) ■ EBITDA: 13,516 (+110.0% YoY | -0.7% QoQ) ■ EBITDA Margin (%): 22.1 (+676 bps YoY | -326 bps QoQ) ■ PAT: 7,147

Aarti Pharmalabs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Aarti Pharmalabs Ltd · Outcome · 29 Oct 2026, 2:25 am

Aarti Pharmalabs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 61,045 (+45.9% YoY | +13.9% QoQ) ■ EBITDA: 13,516 (+110.0% YoY | -0.7% QoQ) ■ EBITDA Margin (%): 22.1 (+676 bps YoY | -326 bps QoQ) ■ PAT: 7,147 (+248.8% YoY | -6.1% QoQ) ■ EPS (INR): 7.87 (+248.2% YoY | -6.2% QoQ)

Original exchange filing (PDF)

More announcements from Aarti Pharmalabs Ltd

All Aarti Pharmalabs Ltd announcements